MCZ
Brand names,
MCZ
Analogs
MCZ
Brand Names Mixture
MCZ
Chemical_Formula
C27H34N2O7
MCZ
RX_link
http://www.rxlist.com/cgi/generic2/moexip.htm
MCZ
fda sheet
MCZ
msds (material safety sheet)
MCZ
Synthesis Reference
No information avaliable
MCZ
Molecular Weight
498.568 g/mol
MCZ
Melting Point
No information avaliable
MCZ
H2O Solubility
Soluble (about 10% weight-to-volume) in distilled water at room temperature as HCl salt.
MCZ
State
Solid
MCZ
LogP
3.31
MCZ
Dosage Forms
Tablets (scored, coated, containing 7.5 mg or 15 mg of moexipril hydrochloride for oral administration)
MCZ
Indication
For treatment of patients with hypertension.
MCZ
Pharmacology
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.
MCZ
Absorption
Moexipril is incompletely absorbed, with bioavailability as moexiprilat of about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces Cmax and AUC by about 70% and 40% respectively after the ingestion of a low-fat breakfast or by 80% and 50% respectively after the ingestion of a high-fat breakfast.
MCZ
side effects and Toxicity
Human overdoses of moexipril have not been reported. In case reports of overdoses with other ACE inhibitors, hypotension has been the principal adverse effect noted. Single oral doses of 2 g/kg moexipril were associated with significant lethality in mice. Rats, however, tolerated single oral doses of up to 3 g/kg.
MCZ
Patient Information
MCZ
Organisms Affected
Humans and other mammals